Caboxen (Cabozantinib) 20 MG – 90 Capsules


Cabozantinib is a targeted therapy. It is an oral receptor tyrosine kinase inhibitor. Cabozantinib treats metastatic medullary thyroid cancer (MTC), advanced renal cell carcinoma, and patients with hepatocellular cancer (HCC) who have previously received sorafenib.

Caboxen capsule is an alternative medicine to Cometriq, made by Everest Pharmaceuticals Ltd.

Whatsapp +8801922101029